Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Vallese, Denis (2013) In vivo behaviour of human precursors into a dystrophic context. [Ph.D. thesis]

Full text disponibile come:

[img]
Preview
PDF Document
51Mb

Abstract (english)

The Duchenne Muscular Dystrophy (DMD) is a lethal recessive X-linked disease caused by mutations in the dystrophin gene, no effective treatment is available up to date. The development of effective therapies requires the use of animal models both dystrophic and immunotolerant for human cells.
In collaboration with James Di Santo at the Pasteur Institute, a new mutant strain of mice was created: the Rag2−Il2rb−Dmd−. This mutant lacks T and B cells, as well as NK cells. It also harbours a mutation in the dystrophin gene.
This study focuses on the morphological and immunohistochemical characterization of the muscle phenotype of the new mutant mouse, its comparison with the most used DMD model (mdx) and its potential use to evaluate the regenerative potential of human myogenic progenitors.
The results obtained in this thesis have shown that the dystrophic phenotype is similar between the two models. Analysis of muscle regeneration has yielded very promising results. The Rag2−Il2rb−Dmd− mouse shows a peak of spontaneous regeneration between 10 and 16 weeks, which is six weeks of intense regeneration.
Results obtained after transplantation of human myoblasts have confirmed that this new model is very suitable for myogenic cells transplantation, which can effectively participate in muscle regeneration. This is very important because allows to study the behaviour of human myogenic stem cells in natural dystrophic context.

Abstract (italian)

La distrofia muscolare di Duchenne (DMD) è una malattia letale recessiva legata al cromosoma X causata da mutazioni nel gene della distrofina, nessun trattamento efficace è disponibile al momento. Lo sviluppo di terapie efficaci richiede l'uso di modelli animali sia distrofici che immunotolleranti per le cellule umane.
In collaborazione con James Di Santo presso l'Istituto Pasteur di Parigi abbiamo sviluppato un nuovo modello di topo mutante: il modello Rag2-Il2rb-Dmd-. Questo mutante manca di cellule T e B, così come cellule NK. Inoltre comprende una mutazione nel gene della distrofina.
Questo studio si concentra sulla caratterizzazione morfologica e immunoistochimica del fenotipo muscolare del nuovo modello murino, il confronto con il modello DMD più usato (mdx) e il suo uso potenziale per valutare il potenziale rigenerativo di progenitori miogenici umani.
I risultati ottenuti in questa tesi hanno dimostrato che il fenotipo distrofico è simile tra i due modelli analizzati. L'analisi della rigenerazione muscolare ha dato risultati molto promettenti. Il topo Rag2-Il2rb-DMD- mostra un picco di rigenerazione spontanea tra le 10 e le 16 settimane di età.
I risultati ottenuti dopo il trapianto di mioblasti umani hanno confermato che questo nuovo modello è molto adatto per il trapianto di cellule umane a potenziale miogenico, in grado di partecipare in modo efficace nella rigenerazione muscolare. Ciò è molto importante perché consente di studiare il comportamento delle cellule staminali miogeniche umane in un contesto naturale di distrofia muscolare.

Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Vitiello, Libero and Mouly, Vincent
Ph.D. course:Ciclo 25 > Scuole 25 > BIOSCIENZE E BIOTECNOLOGIE > GENETICA E BIOLOGIA MOLECOLARE DELLO SVILUPPO
Data di deposito della tesi:23 May 2013
Anno di Pubblicazione:06 May 2013
Key Words:DMD, cell-therapy, mdx, myogenic stem cells ; muscle regeneration ; muscular dystrophies DMD, terapia cellulare, distrofia muscolare, rigenerazione muscolare
Settori scientifico-disciplinari MIUR:Area 05 - Scienze biologiche > BIO/11 Biologia molecolare
Area 05 - Scienze biologiche > BIO/18 Genetica
Struttura di riferimento:Dipartimenti > Dipartimento di Biologia
Codice ID:6114
Depositato il:14 Oct 2013 12:19
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

Aartsma-Rus, A. 2010. Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy. RNA Biol. 7:453-461. Cerca con Google

Aartsma-Rus, A., W.E. Kaman, M. Bremmer-Bout, A.A. Janson, J.T. den Dunnen, G.J. van Ommen, and J.C. van Deutekom. 2004. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther. 11:1391-1398. Cerca con Google

Aartsma-Rus, A., J.C. Van Deutekom, I.F. Fokkema, G.J. Van Ommen, and J.T. Den Dunnen. 2006. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 34:135-144. Cerca con Google

Acsadi, G., G. Dickson, D.R. Love, A. Jani, F.S. Walsh, A. Gurusinghe, J.A. Wolff, and K.E. Davies. 1991. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 352:815-818. Cerca con Google

Agbulut, O., P. Noirez, F. Beaumont, and G. Butler-Browne. 2003. Myosin heavy chain isoforms in postnatal muscle development of mice. Biol Cell. 95:399-406. Cerca con Google

Allamand, V., and K.P. Campbell. 2000. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet. 9:2459-2467. Cerca con Google

Allen, R.E., and L.K. Boxhorn. 1989. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol. 138:311-315. Cerca con Google

Alter, J., F. Lou, A. Rabinowitz, H. Yin, J. Rosenfeld, S.D. Wilton, T.A. Partridge, and Q.L. Lu. 2006. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med. 12:175-177. Cerca con Google

Andreetta, F., P. Bernasconi, F. Baggi, P. Ferro, L. Oliva, E. Arnoldi, F. Cornelio, R. Mantegazza, and P. Confalonieri. 2006. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy. J Neuroimmunol. 175:77-86. Cerca con Google

Ardite, E., E. Perdiguero, B. Vidal, S. Gutarra, A.L. Serrano, and P. Munoz-Canoves. 2012. PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol. 196:163-175. Cerca con Google

Arechavala-Gomeza, V., I.R. Graham, L.J. Popplewell, A.M. Adams, A. Aartsma-Rus, M. Kinali, J.E. Morgan, J.C. van Deutekom, S.D. Wilton, G. Dickson, and F. Muntoni. 2007. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther. 18:798-810. Cerca con Google

Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R.K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med. 204:1057-1069. Cerca con Google

Barberi, T., M. Bradbury, Z. Dincer, G. Panagiotakos, N.D. Socci, and L. Studer. 2007. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med. 13:642-648. Cerca con Google

Barton-Davis, E.R., L. Cordier, D.I. Shoturma, S.E. Leland, and H.L. Sweeney. 1999. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest. 104:375-381. Cerca con Google

Beard, B.C., K.A. Keyser, G.D. Trobridge, L.J. Peterson, D.G. Miller, M. Jacobs, R. Kaul, and H.P. Kiem. 2007. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum Gene Ther. 18:423-434. Cerca con Google

Benchaouir, R., M. Meregalli, A. Farini, G. D'Antona, M. Belicchi, A. Goyenvalle, M. Battistelli, N. Bresolin, R. Bottinelli, L. Garcia, and Y. Torrente. 2007. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell. 1:646-657. Cerca con Google

Bencze, M., E. Negroni, D. Vallese, H. Yacoub-Youssef, S. Chaouch, A. Wolff, A. Aamiri, J.P. Di Santo, B. Chazaud, G. Butler-Browne, W. Savino, V. Mouly, and I. Riederer. 2012. Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther. 20:2168-2179. Cerca con Google

Beroud, C., S. Tuffery-Giraud, M. Matsuo, D. Hamroun, V. Humbertclaude, N. Monnier, M.P. Moizard, M.A. Voelckel, L.M. Calemard, P. Boisseau, M. Blayau, C. Philippe, M. Cossee, M. Pages, F. Rivier, O. Danos, L. Garcia, and M. Claustres. 2007. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy. Hum Mutat. 28:196-202. Cerca con Google

Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. Cerca con Google

Bianco, P., P.G. Robey, I. Saggio, and M. Riminucci. 2010. "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther. 21:1057-1066. Cerca con Google

Bingle, L., N.J. Brown, and C.E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 196:254-265. Cerca con Google

Bione, S., E. Maestrini, S. Rivella, M. Mancini, S. Regis, G. Romeo, and D. Toniolo. 1994. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 8:323-327. Cerca con Google

Bodnar, M.S., J.J. Meneses, R.T. Rodriguez, and M.T. Firpo. 2004. Propagation and maintenance of undifferentiated human embryonic stem cells. Stem Cells Dev. 13:243-253. Cerca con Google

Bondesen, B.A., S.T. Mills, and G.K. Pavlath. 2006. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol. 290:C1651-1659. Cerca con Google

Bonifati, M.D., G. Ruzza, P. Bonometto, A. Berardinelli, K. Gorni, S. Orcesi, G. Lanzi, and C. Angelini. 2000. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve. 23:1344-1347. Cerca con Google

Bonne, G., M.R. Di Barletta, S. Varnous, H.M. Becane, E.H. Hammouda, L. Merlini, F. Muntoni, C.R. Greenberg, F. Gary, J.A. Urtizberea, D. Duboc, M. Fardeau, D. Toniolo, and K. Schwartz. 1999. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 21:285-288. Cerca con Google

Bottinelli, R., and C. Reggiani. 2000. Human skeletal muscle fibres: molecular and functional diversity. Prog Biophys Mol Biol. 73:195-262. Cerca con Google

Bulfield, G., W.G. Siller, P.A. Wight, and K.J. Moore. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 81:1189-1192. Cerca con Google

Cantini, M., M.L. Massimino, A. Bruson, C. Catani, L. Dalla Libera, and U. Carraro. 1994. Macrophages regulate proliferation and differentiation of satellite cells. Biochem Biophys Res Commun. 202:1688-1696. Cerca con Google

Caplan, A.I. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 213:341-347. Cerca con Google

Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 25:2739-2749. Cerca con Google

Chapman, V.M., D.R. Miller, D. Armstrong, and C.T. Caskey. 1989. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A. 86:1292-1296. Cerca con Google

Charge, S.B., and M.A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 84:209-238. Cerca con Google

Chazaud, B., C. Sonnet, P. Lafuste, G. Bassez, A.C. Rimaniol, F. Poron, F.J. Authier, P.A. Dreyfus, and R.K. Gherardi. 2003. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol. 163:1133-1143. Cerca con Google

Cirak, S., L. Feng, K. Anthony, V. Arechavala-Gomeza, S. Torelli, C. Sewry, J.E. Morgan, and F. Muntoni. 2011. Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther. 20:462-467. Cerca con Google

Clark, E.A., L.D. Shultz, and S.B. Pollack. 1981. Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics. 12:601-613. Cerca con Google

Colucci, F., C. Soudais, E. Rosmaraki, L. Vanes, V.L. Tybulewicz, and J.P. Di Santo. 1999. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J Immunol. 162:2761-2765. Cerca con Google

Contreras-Shannon, V., O. Ochoa, S.M. Reyes-Reyna, D. Sun, J.E. Michalek, W.A. Kuziel, L.M. McManus, and P.K. Shireman. 2007. Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury. Am J Physiol Cell Physiol. 292:C953-967. Cerca con Google

Cooper, B.J., N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, L.M. Kunkel, M.O. Scott, K.H. Fischbeck, J.N. Kornegay, R.J. Avery, and et al. 1988. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature. 334:154-156. Cerca con Google

Cooper, R.N., S. Tajbakhsh, V. Mouly, G. Cossu, M. Buckingham, and G.S. Butler-Browne. 1999. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci. 112 ( Pt 17):2895-2901. Cerca con Google

Cooper, R.N., D. Thiesson, D. Furling, J.P. Di Santo, G.S. Butler-Browne, and V. Mouly. 2003. Extended amplification in vitro and replicative senescence: key factors implicated in the success of human myoblast transplantation. Hum Gene Ther. 14:1169-1179. Cerca con Google

Cornelison, D.D., M.S. Filla, H.M. Stanley, A.C. Rapraeger, and B.B. Olwin. 2001. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol. 239:79-94. Cerca con Google

Cornelison, D.D., and B.J. Wold. 1997. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol. 191:270-283. Cerca con Google

Cossu, G., and P. Bianco. 2003. Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev. 13:537-542. Cerca con Google

Cox, G.A., S.F. Phelps, V.M. Chapman, and J.S. Chamberlain. 1993. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet. 4:87-93. Cerca con Google

Danko, I., V. Chapman, and J.A. Wolff. 1992. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res. 32:128-131. Cerca con Google

Danko, I., J.D. Fritz, J.S. Latendresse, H. Herweijer, E. Schultz, and J.A. Wolff. 1993. Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum Mol Genet. 2:2055-2061. Cerca con Google

De Angelis, L., L. Berghella, M. Coletta, L. Lattanzi, M. Zanchi, M.G. Cusella-De Angelis, C. Ponzetto, and G. Cossu. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol. 147:869-878. Cerca con Google

De Bari, C., F. Dell'Accio, F. Vandenabeele, J.R. Vermeesch, J.M. Raymackers, and F.P. Luyten. 2003. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 160:909-918. Cerca con Google

de Greef, J.C., R.J. Lemmers, P. Camano, J.W. Day, S. Sacconi, M. Dunand, B.G. van Engelen, S. Kiuru-Enari, G.W. Padberg, A.L. Rosa, C. Desnuelle, S. Spuler, M. Tarnopolsky, S.L. Venance, R.R. Frants, S.M. van der Maarel, and R. Tawil. 2010. Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology. 75:1548-1554. Cerca con Google

De Sandre-Giovannoli, A., R. Bernard, P. Cau, C. Navarro, J. Amiel, I. Boccaccio, S. Lyonnet, C.L. Stewart, A. Munnich, M. Le Merrer, and N. Levy. 2003. Lamin a truncation in Hutchinson-Gilford progeria. Science. 300:2055. Cerca con Google

De Sandre-Giovannoli, A., M. Chaouch, S. Kozlov, J.M. Vallat, M. Tazir, N. Kassouri, P. Szepetowski, T. Hammadouche, A. Vandenberghe, C.L. Stewart, D. Grid, and N. Levy. 2002. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 70:726-736. Cerca con Google

Deconinck, A.E., J.A. Rafael, J.A. Skinner, S.C. Brown, A.C. Potter, L. Metzinger, D.J. Watt, J.G. Dickson, J.M. Tinsley, and K.E. Davies. 1997. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90:717-727. Cerca con Google

Dellavalle, A., M. Sampaolesi, R. Tonlorenzi, E. Tagliafico, B. Sacchetti, L. Perani, A. Innocenzi, B.G. Galvez, G. Messina, R. Morosetti, S. Li, M. Belicchi, G. Peretti, J.S. Chamberlain, W.E. Wright, Y. Torrente, S. Ferrari, P. Bianco, and G. Cossu. 2007. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol. Cerca con Google

Dellorusso, C., R.W. Crawford, J.S. Chamberlain, and S.V. Brooks. 2001. Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil. 22:467-475. Cerca con Google

Desguerre, I., L. Arnold, A. Vignaud, S. Cuvellier, H. Yacoub-Youssef, R.K. Gherardi, J. Chelly, F. Chretien, R. Mounier, A. Ferry, and B. Chazaud. 2012. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy. Muscle Nerve. 45:803-814. Cerca con Google

Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8:315-317. Cerca con Google

Dorshkind, K., S.B. Pollack, M.J. Bosma, and R.A. Phillips. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 134:3798-3801. Cerca con Google

Edwards, J.P., X. Zhang, K.A. Frauwirth, and D.M. Mosser. 2006. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 80:1298-1307. Cerca con Google

Ehmsen, J., E. Poon, and K. Davies. 2002. The dystrophin-associated protein complex. J Cell Sci. 115:2801-2803. Cerca con Google

Emery, A.E. 2002. The muscular dystrophies. Lancet. 359:687-695. Cerca con Google

England, S.B., L.V. Nicholson, M.A. Johnson, S.M. Forrest, D.R. Love, E.E. Zubrzycka-Gaarn, D.E. Bulman, J.B. Harris, and K.E. Davies. 1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 343:180-182. Cerca con Google

Eriksson, M., W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, C.M. Robbins, T.Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A.B. Csoka, M. Boehnke, T.W. Glover, and F.S. Collins. 2003. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 423:293-298. Cerca con Google

Fabb, S.A., D.J. Wells, P. Serpente, and G. Dickson. 2002. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice. Hum Mol Genet. 11:733-741. Cerca con Google

Farini, A., M. Meregalli, M. Belicchi, M. Battistelli, D. Parolini, G. D'Antona, M. Gavina, L. Ottoboni, G. Constantin, R. Bottinelli, and Y. Torrente. 2007. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J Pathol. 213:229-238. Cerca con Google

Ferrari, G., A. Stornaiuolo, and F. Mavilio. 2001. Failure to correct murine muscular dystrophy. Nature. 411:1014-1015. Cerca con Google

Finkel, R.S. 2010. Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). J Child Neurol. 25:1158-1164. Cerca con Google

Flanagan, S.P. 1966. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res. 8:295-309. Cerca con Google

Fletcher, S., K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, J.P. Steinhaus, H.M. Moulton, P.L. Iversen, and S.D. Wilton. 2007. Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther. 15:1587-1592. Cerca con Google

Fletcher, S., K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, and S.D. Wilton. 2006. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J Gene Med. 8:207-216. Cerca con Google

Foster, H., P.S. Sharp, T. Athanasopoulos, C. Trollet, I.R. Graham, K. Foster, D.J. Wells, and G. Dickson. 2008. Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer. Mol Ther. 16:1825-1832. Cerca con Google

Frenette, J., B. Cai, and J.G. Tidball. 2000. Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol. 156:2103-2110. Cerca con Google

Fuchtbauer, E.M., and H. Westphal. 1992. MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev Dyn. 193:34-39. Cerca con Google

Fukada, S., S. Higuchi, M. Segawa, K. Koda, Y. Yamamoto, K. Tsujikawa, Y. Kohama, A. Uezumi, M. Imamura, Y. Miyagoe-Suzuki, S. Takeda, and H. Yamamoto. 2004. Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res. 296:245-255. Cerca con Google

Gal-Levi, R., Y. Leshem, S. Aoki, T. Nakamura, and O. Halevy. 1998. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochim Biophys Acta. 1402:39-51. Cerca con Google

Gebski, B.L., C.J. Mann, S. Fletcher, and S.D. Wilton. 2003. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum Mol Genet. 12:1801-1811. Cerca con Google

Goemans, N.M., M. Tulinius, J.T. van den Akker, B.E. Burm, P.F. Ekhart, N. Heuvelmans, T. Holling, A.A. Janson, G.J. Platenburg, J.A. Sipkens, J.M. Sitsen, A. Aartsma-Rus, G.J. van Ommen, G. Buyse, N. Darin, J.J. Verschuuren, G.V. Campion, S.J. de Kimpe, and J.C. van Deutekom. 2011. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med. 364:1513-1522. Cerca con Google

Goldman, J.P., M.P. Blundell, L. Lopes, C. Kinnon, J.P. Di Santo, and A.J. Thrasher. 1998. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol. 103:335-342. Cerca con Google

Golumbek, P.T., R.M. Keeling, and A.M. Connolly. 2007a. RAG2 gene knockout in mice causes fatigue. Muscle Nerve. 36:471-476. Cerca con Google

Golumbek, P.T., R.M. Keeling, and A.M. Connolly. 2007b. Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Neuromuscul Disord. 17:376-384. Cerca con Google

Gordon, S. 2003. Alternative activation of macrophages. Nat Rev Immunol. 3:23-35. Cerca con Google

Gordon, S., and P.R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 5:953-964. Cerca con Google

Goudenege, S., D.F. Pisani, B. Wdziekonski, J.P. Di Santo, C. Bagnis, C. Dani, and C.A. Dechesne. 2009. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther. 17:1064-1072. Cerca con Google

Grady, R.M., H. Teng, M.C. Nichol, J.C. Cunningham, R.S. Wilkinson, and J.R. Sanes. 1997. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90:729-738. Cerca con Google

Graham, I.R., V.J. Hill, M. Manoharan, G.B. Inamati, and G. Dickson. 2004. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. J Gene Med. 6:1149-1158. Cerca con Google

Gregorevic, P., J.M. Allen, E. Minami, M.J. Blankinship, M. Haraguchi, L. Meuse, E. Finn, M.E. Adams, S.C. Froehner, C.E. Murry, and J.S. Chamberlain. 2006. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med. 12:787-789. Cerca con Google

Gregorevic, P., M.J. Blankinship, J.M. Allen, R.W. Crawford, L. Meuse, D.G. Miller, D.W. Russell, and J.S. Chamberlain. 2004. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med. 10:828-834. Cerca con Google

Hacein-Bey-Abina, S., A. Garrigue, G.P. Wang, J. Soulier, A. Lim, E. Morillon, E. Clappier, L. Caccavelli, E. Delabesse, K. Beldjord, V. Asnafi, E. MacIntyre, L. Dal Cortivo, I. Radford, N. Brousse, F. Sigaux, D. Moshous, J. Hauer, A. Borkhardt, B.H. Belohradsky, U. Wintergerst, M.C. Velez, L. Leiva, R. Sorensen, N. Wulffraat, S. Blanche, F.D. Bushman, A. Fischer, and M. Cavazzana-Calvo. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 118:3132-3142. Cerca con Google

Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. Wissler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302:415-419. Cerca con Google

Hackman, P., A. Vihola, H. Haravuori, S. Marchand, J. Sarparanta, J. De Seze, S. Labeit, C. Witt, L. Peltonen, I. Richard, and B. Udd. 2002. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet. 71:492-500. Cerca con Google

Harper, S.Q., M.A. Hauser, C. DelloRusso, D. Duan, R.W. Crawford, S.F. Phelps, H.A. Harper, A.S. Robinson, J.F. Engelhardt, S.V. Brooks, and J.S. Chamberlain. 2002. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med. 8:253-261. Cerca con Google

Hartikka, J., L. Sukhu, C. Buchner, D. Hazard, V. Bozoukova, M. Margalith, W.K. Nishioka, C.J. Wheeler, M. Manthorp, and M. Sawdey. 2001. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther. 4:407-415. Cerca con Google

Hawke, T.J., and D.J. Garry. 2001. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol. 91:534-551. Cerca con Google

Hirst, R.C., K.J. McCullagh, and K.E. Davies. 2005. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol. 24:209-216. Cerca con Google

Ichida, J.K., J. Blanchard, K. Lam, E.Y. Son, J.E. Chung, D. Egli, K.M. Loh, A.C. Carter, F.P. Di Giorgio, K. Koszka, D. Huangfu, H. Akutsu, D.R. Liu, L.L. Rubin, and K. Eggan. 2009. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell. 5:491-503. Cerca con Google

Jackson, W.M., L.J. Nesti, and R.S. Tuan. 2010. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther. 10:505-517. Cerca con Google

Kafri, T., U. Blomer, D.A. Peterson, F.H. Gage, and I.M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet. 17:314-317. Cerca con Google

Katz, B. 1961. Terminations of afferent nerve fibre in muscle spindle of frog. In Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, London. 221-240. Cerca con Google

Kinali, M., V. Arechavala-Gomeza, L. Feng, S. Cirak, D. Hunt, C. Adkin, M. Guglieri, E. Ashton, S. Abbs, P. Nihoyannopoulos, M.E. Garralda, M. Rutherford, C. McCulley, L. Popplewell, I.R. Graham, G. Dickson, M.J. Wood, D.J. Wells, S.D. Wilton, R. Kole, V. Straub, K. Bushby, C. Sewry, J.E. Morgan, and F. Muntoni. 2009. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 8:918-928. Cerca con Google

Kode, J.A., S. Mukherjee, M.V. Joglekar, and A.A. Hardikar. 2009. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 11:377-391. Cerca con Google

Koenig, M., A.P. Monaco, and L.M. Kunkel. 1988. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:219-228. Cerca con Google

Kolls, J.K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity. 21:467-476. Cerca con Google

Koppanati, B.M., J. Li, X. Xiao, and P.R. Clemens. 2009. Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders. Gene Ther. 16:1130-1137. Cerca con Google

Kuwajima, S., T. Sato, K. Ishida, H. Tada, H. Tezuka, and T. Ohteki. 2006. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol. 7:740-746. Cerca con Google

Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 201:233-240. Cerca con Google

Launay, T., A.S. Armand, F. Charbonnier, J.C. Mira, E. Donsez, C.L. Gallien, and C. Chanoine. 2001. Expression and neural control of myogenic regulatory factor genes during regeneration of mouse soleus. J Histochem Cytochem. 49:887-899. Cerca con Google

Lee, K.Y., and D.J. Mooney. 2001. Hydrogels for tissue engineering. Chem Rev. 101:1869-1879. Cerca con Google

Lemmers, R.J., P. de Kievit, L. Sandkuijl, G.W. Padberg, G.J. van Ommen, R.R. Frants, and S.M. van der Maarel. 2002. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet. 32:235-236. Cerca con Google

Lemmers, R.J., R. Tawil, L.M. Petek, J. Balog, G.J. Block, G.W. Santen, A.M. Amell, P.J. van der Vliet, R. Almomani, K.R. Straasheijm, Y.D. Krom, R. Klooster, Y. Sun, J.T. den Dunnen, Q. Helmer, C.M. Donlin-Smith, G.W. Padberg, B.G. van Engelen, J.C. de Greef, A.M. Aartsma-Rus, R.R. Frants, M. de Visser, C. Desnuelle, S. Sacconi, G.N. Filippova, B. Bakker, M.J. Bamshad, S.J. Tapscott, D.G. Miller, and S.M. van der Maarel. 2012. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 44:1370-1374. Cerca con Google

Lescaudron, L., E. Peltekian, J. Fontaine-Perus, D. Paulin, M. Zampieri, L. Garcia, and E. Parrish. 1999. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord. 9:72-80. Cerca con Google

Leshem, Y., D.B. Spicer, R. Gal-Levi, and O. Halevy. 2000. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. J Cell Physiol. 184:101-109. Cerca con Google

Li, S., E. Kimura, B.M. Fall, M. Reyes, J.C. Angello, R. Welikson, S.D. Hauschka, and J.S. Chamberlain. 2005. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther. 12:1099-1108. Cerca con Google

Lindstrom, M., and L.E. Thornell. 2009. New multiple labelling method for improved satellite cell identification in human muscle: application to a cohort of power-lifters and sedentary men. Histochem Cell Biol. 132:141-157. Cerca con Google

Lipton, B. 1979. Skeletal muscle regeneration in muscular dystrophy. Raven Press, New York. 560 pp. Cerca con Google

Liquori, C.L., K. Ricker, M.L. Moseley, J.F. Jacobsen, W. Kress, S.L. Naylor, J.W. Day, and L.P. Ranum. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 293:864-867. Cerca con Google

Lu, Q.L., C.J. Mann, F. Lou, G. Bou-Gharios, G.E. Morris, S.A. Xue, S. Fletcher, T.A. Partridge, and S.D. Wilton. 2003. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med. 9:1009-1014. Cerca con Google

Lu, Q.L., A. Rabinowitz, Y.C. Chen, T. Yokota, H. Yin, J. Alter, A. Jadoon, G. Bou-Gharios, and T. Partridge. 2005. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci U S A. 102:198-203. Cerca con Google

MacKenzie, T.C., G.P. Kobinger, J.P. Louboutin, A. Radu, E.H. Javazon, M. Sena-Esteves, J.M. Wilson, and A.W. Flake. 2005. Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors. J Gene Med. 7:50-58. Cerca con Google

Mahadevan, M., C. Tsilfidis, L. Sabourin, G. Shutler, C. Amemiya, G. Jansen, C. Neville, M. Narang, J. Barcelo, K. O'Hoy, and et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science. 255:1253-1255. Cerca con Google

Malerba, A., P.S. Sharp, I.R. Graham, V. Arechavala-Gomeza, K. Foster, F. Muntoni, D.J. Wells, and G. Dickson. 2011. Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice. Mol Ther. 19:345-354. Cerca con Google

Malerba, A., F.C. Thorogood, G. Dickson, and I.R. Graham. 2009. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice. Hum Gene Ther. 20:955-965. Cerca con Google

Malik, V., L.R. Rodino-Klapac, L. Viollet, C. Wall, W. King, R. Al-Dahhak, S. Lewis, C.J. Shilling, J. Kota, C. Serrano-Munuera, J. Hayes, J.D. Mahan, K.J. Campbell, B. Banwell, M. Dasouki, V. Watts, K. Sivakumar, R. Bien-Willner, K.M. Flanigan, Z. Sahenk, R.J. Barohn, C.M. Walker, and J.R. Mendell. 2010. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol. 67:771-780. Cerca con Google

Mamchaoui, K., C. Trollet, A. Bigot, E. Negroni, S. Chaouch, A. Wolff, P.K. Kandalla, S. Marie, J. Di Santo, J.L. St Guily, F. Muntoni, J. Kim, S. Philippi, S. Spuler, N. Levy, S.C. Blumen, T. Voit, W.E. Wright, A. Aamiri, G. Butler-Browne, and V. Mouly. 2011. Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle. 1:34. Cerca con Google

Manno, C.S., A.J. Chew, S. Hutchison, P.J. Larson, R.W. Herzog, V.R. Arruda, S.J. Tai, M.V. Ragni, A. Thompson, M. Ozelo, L.B. Couto, D.G. Leonard, F.A. Johnson, A. McClelland, C. Scallan, E. Skarsgard, A.W. Flake, M.A. Kay, K.A. High, and B. Glader. 2003. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 101:2963-2972. Cerca con Google

Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686. Cerca con Google

Manzur, A.Y., T. Kuntzer, M. Pike, and A. Swan. 2008. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev:CD003725. Cerca con Google

Massimino, M.L., E. Rapizzi, M. Cantini, L.D. Libera, F. Mazzoleni, P. Arslan, and U. Carraro. 1997. ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun. 235:754-759. Cerca con Google

Mathieu, J., P. Allard, L. Potvin, C. Prevost, and P. Begin. 1999. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 52:1658-1662. Cerca con Google

Matsumura, K., A.H. Burghes, M. Mora, F.M. Tome, L. Morandi, F. Cornello, F. Leturcq, M. Jeanpierre, J.C. Kaplan, P. Reinert, and et al. 1994. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin. J Clin Invest. 93:99-105. Cerca con Google

Mauro, A. 1961. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 9:493-495. Cerca con Google

Mazurier, F., A. Fontanellas, S. Salesse, L. Taine, S. Landriau, F. Moreau-Gaudry, J. Reiffers, B. Peault, J.P. Di Santo, and H. de Verneuil. 1999. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res. 19:533-541. Cerca con Google

McClorey, G., H.M. Moulton, P.L. Iversen, S. Fletcher, and S.D. Wilton. 2006. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13:1373-1381. Cerca con Google

McLennan, I.S. 1996. Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J Anat. 188 ( Pt 1):17-28. Cerca con Google

McLoon, L.K., L.T. Nguyen, and J. Wirtschafter. 1998. Time course of the regenerative response in bupivacaine injured orbicularis oculi muscle. Cell Tissue Res. 294:439-447. Cerca con Google

Megeney, L.A., B. Kablar, K. Garrett, J.E. Anderson, and M.A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10:1173-1183. Cerca con Google

Meissner, A., M. Wernig, and R. Jaenisch. 2007. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 25:1177-1181. Cerca con Google

Meng, J., C.F. Adkin, V. Arechavala-Gomeza, L. Boldrin, F. Muntoni, and J.E. Morgan. 2010. The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul Disord. 20:6-15. Cerca con Google

Meng, J., F. Muntoni, and J.E. Morgan. 2011. Stem cells to treat muscular dystrophies - where are we? Neuromuscul Disord. 21:4-12. Cerca con Google

Moens, P., P.H. Baatsen, and G. Marechal. 1993. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil. 14:446-451. Cerca con Google

Monaco, A.P., C.J. Bertelson, C. Colletti-Feener, and L.M. Kunkel. 1987. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet. 75:221-227. Cerca con Google

Monaco, A.P., C.J. Bertelson, S. Liechti-Gallati, H. Moser, and L.M. Kunkel. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 2:90-95. Cerca con Google

Monaco, A.P., R.L. Neve, C. Colletti-Feener, C.J. Bertelson, D.M. Kurnit, and L.M. Kunkel. 1986. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 323:646-650. Cerca con Google

Monahan, P.E., R.J. Samulski, J. Tazelaar, X. Xiao, T.C. Nichols, D.A. Bellinger, M.S. Read, and C.E. Walsh. 1998. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5:40-49. Cerca con Google

Morgan, J.E., G.R. Coulton, and T.A. Partridge. 1987. Muscle precursor cells invade and repopulate freeze-killed muscles. J Muscle Res Cell Motil. 8:386-396. Cerca con Google

Morgan, J.E., C.N. Pagel, T. Sherratt, and T.A. Partridge. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci. 115:191-200. Cerca con Google

Morgan, J.E., and T.A. Partridge. 2003. Muscle satellite cells. Int J Biochem Cell Biol. 35:1151-1156. Cerca con Google

Morrison, J., Q.L. Lu, C. Pastoret, T. Partridge, and G. Bou-Gharios. 2000. T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab Invest. 80:881-891. Cerca con Google

Morrison, J., D.B. Palmer, S. Cobbold, T. Partridge, and G. Bou-Gharios. 2005a. Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. Am J Pathol. 166:1701-1710. Cerca con Google

Morrison, J., T. Partridge, and G. Bou-Gharios. 2005b. Nude mutation influences limb skeletal muscle development. Matrix biology : journal of the International Society for Matrix Biology. 23:535-542. Cerca con Google

Mosser, D.M. 2003. The many faces of macrophage activation. J Leukoc Biol. 73:209-212. Cerca con Google

Mosser, D.M., and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8:958-969. Cerca con Google

Muchir, A., G. Bonne, A.J. van der Kooi, M. van Meegen, F. Baas, P.A. Bolhuis, M. de Visser, and K. Schwartz. 2000. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet. 9:1453-1459. Cerca con Google

Murphy, W.J., S.K. Durum, M.R. Anver, D.K. Ferris, D.W. McVicar, J.J. O'Shea, S.K. Ruscetti, M.R. Smith, H.A. Young, and D.L. Longo. 1994. Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J Immunol. 153:1004-1014. Cerca con Google

Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol. 158:97-129. Cerca con Google

Negroni, E., I. Riederer, S. Chaouch, M. Belicchi, P. Razini, J. Di Santo, Y. Torrente, G.S. Butler-Browne, and V. Mouly. 2009. In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther. 17:1771-1778. Cerca con Google

Negroni, E., D. Vallese, J.T. Vilquin, G. Butler-Browne, V. Mouly, and C. Trollet. 2011. Current advances in cell therapy strategies for muscular dystrophies. Expert Opin Biol Ther. 11:157-176. Cerca con Google

Nguyen, H.X., and J.G. Tidball. 2003. Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J Physiol. 550:347-356. Cerca con Google

Nigro, V. 2003. Molecular bases of autosomal recessive limb-girdle muscular dystrophies. Acta Myol. 22:35-42. Cerca con Google

Okita, K., M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 322:949-953. Cerca con Google

Pantelouris, E.M. 1968. Absence of thymus in a mouse mutant. Nature. 217:370-371. Cerca con Google

Park, I.H., N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, M.W. Lensch, C. Cowan, K. Hochedlinger, and G.Q. Daley. 2008. Disease-specific induced pluripotent stem cells. Cell. 134:877-886. Cerca con Google

Partridge, T.A., M. Grounds, and J.C. Sloper. 1978. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature. 273:306-308. Cerca con Google

Pastoret, C., and A. Sebille. 1995. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci. 129:97-105. Cerca con Google

Peault, B., M. Rudnicki, Y. Torrente, G. Cossu, J.P. Tremblay, T. Partridge, E. Gussoni, L.M. Kunkel, and J. Huard. 2007. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 15:867-877. Cerca con Google

Perie, S., K. Mamchaoui, V. Mouly, S. Blot, B. Bouazza, L.E. Thornell, J.L. St Guily, and G. Butler-Browne. 2006. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation. Neuromuscul Disord. 16:770-781. Cerca con Google

Petrof, B.J., J.B. Shrager, H.H. Stedman, A.M. Kelly, and H.L. Sweeney. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A. 90:3710-3714. Cerca con Google

Pimorady-Esfahani, A., M.D. Grounds, and P.G. McMenamin. 1997. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve. 20:158-166. Cerca con Google

Podsakoff, G., K.K. Wong, Jr., and S. Chatterjee. 1994. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol. 68:5656-5666. Cerca con Google

Popplewell, L.J., C. Adkin, V. Arechavala-Gomeza, A. Aartsma-Rus, C.L. de Winter, S.D. Wilton, J.E. Morgan, F. Muntoni, I.R. Graham, and G. Dickson. 2010. Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials. Neuromuscul Disord. 20:102-110. Cerca con Google

Price, F.D., K. Kuroda, and M.A. Rudnicki. 2007. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta. 1772:272-283. Cerca con Google

Rabinowitz, J.E., and J. Samulski. 1998. Adeno-associated virus expression systems for gene transfer. Curr Opin Biotechnol. 9:470-475. Cerca con Google

Rando, T.A. 2001. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve. 24:1575-1594. Cerca con Google

Ranum, L.P., and J.W. Day. 2002. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr Neurol Neurosci Rep. 2:465-470. Cerca con Google

Renault, V., L.E. Thornell, P.O. Eriksson, G. Butler-Browne, and V. Mouly. 2002. Regenerative potential of human skeletal muscle during aging. Aging Cell. 1:132-139. Cerca con Google

Riederer, I., E. Negroni, M. Bencze, A. Wolff, A. Aamiri, J.P. Di Santo, S.D. Silva-Barbosa, G. Butler-Browne, W. Savino, and V. Mouly. 2012. Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration. Mol Ther. 20:146-154. Cerca con Google

Robertson, T.A., M.A. Maley, M.D. Grounds, and J.M. Papadimitriou. 1993. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res. 207:321-331. Cerca con Google

Rodriguez, A.M., D. Pisani, C.A. Dechesne, C. Turc-Carel, J.Y. Kurzenne, B. Wdziekonski, A. Villageois, C. Bagnis, J.P. Breittmayer, H. Groux, G. Ailhaud, and C. Dani. 2005. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med. 201:1397-1405. Cerca con Google

Rossi, C.A., M. Flaibani, B. Blaauw, M. Pozzobon, E. Figallo, C. Reggiani, L. Vitiello, N. Elvassore, and P. De Coppi. 2011. In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. FASEB J. 25:2296-2304. Cerca con Google

Sacco, A., F. Mourkioti, R. Tran, J. Choi, M. Llewellyn, P. Kraft, M. Shkreli, S. Delp, J.H. Pomerantz, S.E. Artandi, and H.M. Blau. 2010. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 143:1059-1071. Cerca con Google

Sakamoto, M., K. Yuasa, M. Yoshimura, T. Yokota, T. Ikemoto, M. Suzuki, G. Dickson, Y. Miyagoe-Suzuki, and S. Takeda. 2002. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun. 293:1265-1272. Cerca con Google

Sampaolesi, M., S. Blot, G. D'Antona, N. Granger, R. Tonlorenzi, A. Innocenzi, P. Mognol, J.L. Thibaud, B.G. Galvez, I. Barthelemy, L. Perani, S. Mantero, M. Guttinger, O. Pansarasa, C. Rinaldi, M.G. Cusella De Angelis, Y. Torrente, C. Bordignon, R. Bottinelli, and G. Cossu. 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 444:574-579. Cerca con Google

Sampaolesi, M., Y. Torrente, A. Innocenzi, R. Tonlorenzi, G. D'Antona, M.A. Pellegrino, R. Barresi, N. Bresolin, M.G. De Angelis, K.P. Campbell, R. Bottinelli, and G. Cossu. 2003. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science. 301:487-492. Cerca con Google

Sandri, M., A.H. El Meslemani, C. Sandri, P. Schjerling, K. Vissing, J.L. Andersen, K. Rossini, U. Carraro, and C. Angelini. 2001. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol. 60:302-312. Cerca con Google

Schabort, E.J., M. van der Merwe, B. Loos, F.P. Moore, and C.U. Niesler. 2009. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. Exp Cell Res. 315:373-384. Cerca con Google

Schultz, E., and B.H. Lipton. 1982. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev. 20:377-383. Cerca con Google

Sellers, J.R., H.V. Goodson, and F. Wang. 1996. A myosin family reunion. J Muscle Res Cell Motil. 17:7-22. Cerca con Google

Sheehan, S.M., and R.E. Allen. 1999. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol. 181:499-506. Cerca con Google

Shelton, G.D., and E. Engvall. 2005. Canine and feline models of human inherited muscle diseases. Neuromuscul Disord. 15:127-138. Cerca con Google

Shi, M., M. Ishikawa, N. Kamei, T. Nakasa, N. Adachi, M. Deie, T. Asahara, and M. Ochi. 2009. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells. 27:949-960. Cerca con Google

Shimatsu, Y., K. Katagiri, T. Furuta, M. Nakura, Y. Tanioka, K. Yuasa, M. Tomohiro, J.N. Kornegay, I. Nonaka, and S. Takeda. 2003. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim. 52:93-97. Cerca con Google

Shinkai, Y., G. Rathbun, K.P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:855-867. Cerca con Google

Sicinski, P., Y. Geng, A.S. Ryder-Cook, E.A. Barnard, M.G. Darlison, and P.J. Barnard. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1578-1580. Cerca con Google

Silva-Barbosa, S.D., G.S. Butler-Browne, W. de Mello, I. Riederer, J.P. Di Santo, W. Savino, and V. Mouly. 2008. Human myoblast engraftment is improved in laminin-enriched microenvironment. Transplantation. 85:566-575. Cerca con Google

Silva-Barbosa, S.D., G.S. Butler-Browne, J.P. Di Santo, and V. Mouly. 2005. Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation. Cell Transplant. 14:457-467. Cerca con Google

Snow, M.H. 1977. The effects of aging on satellite cells in skeletal muscles of mice and rats. Cell Tissue Res. 185:399-408. Cerca con Google

Sonnet, C., P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F.J. Authier, F. Chretien, R.K. Gherardi, and B. Chazaud. 2006. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci. 119:2497-2507. Cerca con Google

Soussi-Yanicostas, N., R.G. Whalen, and C. Petit. 1993. Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. Hum Mol Genet. 2:563-569. Cerca con Google

Stedman, H.H., H.L. Sweeney, J.B. Shrager, H.C. Maguire, R.A. Panettieri, B. Petrof, M. Narusawa, J.M. Leferovich, J.T. Sladky, and A.M. Kelly. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:536-539. Cerca con Google

Swijnenburg, R.J., M. Tanaka, H. Vogel, J. Baker, T. Kofidis, F. Gunawan, D.R. Lebl, A.D. Caffarelli, J.L. de Bruin, E.V. Fedoseyeva, and R.C. Robbins. 2005. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation. 112:I166-172. Cerca con Google

Tajbakhsh, S., E. Bober, C. Babinet, S. Pournin, H. Arnold, and M. Buckingham. 1996. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev Dyn. 206:291-300. Cerca con Google

Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131:861-872. Cerca con Google

Takeshima, Y., M. Yagi, H. Wada, K. Ishibashi, A. Nishiyama, M. Kakumoto, T. Sakaeda, R. Saura, K. Okumura, and M. Matsuo. 2006. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Pediatr Res. 59:690-694. Cerca con Google

Tatsumi, R., S.M. Sheehan, H. Iwasaki, A. Hattori, and R.E. Allen. 2001. Mechanical stretch induces activation of skeletal muscle satellite cells in vitro. Exp Cell Res. 267:107-114. Cerca con Google

Tawil, R., and S.M. Van Der Maarel. 2006. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 34:1-15. Cerca con Google

Tedesco, F.S., and G. Cossu. 2012. Stem cell therapies for muscle disorders. Current opinion in neurology. 25:597-603. Cerca con Google

Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 282:1145-1147. Cerca con Google

Tidball, J.G. 2005. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 288:R345-353. Cerca con Google

Tidball, J.G., E. Berchenko, and J. Frenette. 1999. Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol. 65:492-498. Cerca con Google

Tidball, J.G., and S.A. Villalta. 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 298:R1173-1187. Cerca con Google

Tinsley, J.M., R.J. Fairclough, R. Storer, F.J. Wilkes, A.C. Potter, S.E. Squire, D.S. Powell, A. Cozzoli, R.F. Capogrosso, A. Lambert, F.X. Wilson, S.P. Wren, A. De Luca, and K.E. Davies. 2011. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One. 6:e19189. Cerca con Google

Torrente, Y., M. Belicchi, C. Marchesi, G. Dantona, F. Cogiamanian, F. Pisati, M. Gavina, R. Giordano, R. Tonlorenzi, G. Fagiolari, C. Lamperti, L. Porretti, R. Lopa, M. Sampaolesi, L. Vicentini, N. Grimoldi, F. Tiberio, V. Songa, P. Baratta, A. Prelle, L. Forzenigo, M. Guglieri, O. Pansarasa, C. Rinaldi, V. Mouly, G.S. Butler-Browne, G.P. Comi, P. Biondetti, M. Moggio, S.M. Gaini, N. Stocchetti, A. Priori, M.G. D'Angelo, A. Turconi, R. Bottinelli, G. Cossu, P. Rebulla, and N. Bresolin. 2007. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant. 16:563-577. Cerca con Google

Torrente, Y., M. Belicchi, M. Sampaolesi, F. Pisati, M. Meregalli, G. D'Antona, R. Tonlorenzi, L. Porretti, M. Gavina, K. Mamchaoui, M.A. Pellegrino, D. Furling, V. Mouly, G.S. Butler-Browne, R. Bottinelli, G. Cossu, and N. Bresolin. 2004. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest. 114:182-195. Cerca con Google

Tremblay, J.P., J.P. Bouchard, F. Malouin, D. Theau, F. Cottrell, H. Collin, A. Rouche, S. Gilgenkrantz, N. Abbadi, M. Tremblay, and et al. 1993. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul Disord. 3:583-592. Cerca con Google

Tsilfidis, C., A.E. MacKenzie, G. Mettler, J. Barcelo, and R.G. Korneluk. 1992. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet. 1:192-195. Cerca con Google

Umehara, H., and E.T. Bloom. 1990. The IL-2 receptor beta subunit is absolutely required for mediating the IL-2-induced activation of NK activity and proliferative activity of human large granular lymphocytes. Immunology. 70:111-115. Cerca con Google

Vainzof, M., D. Ayub-Guerrieri, P.C. Onofre, P.C. Martins, V.F. Lopes, D. Zilberztajn, L.S. Maia, K. Sell, and L.U. Yamamoto. 2008. Animal models for genetic neuromuscular diseases. J Mol Neurosci. 34:241-248. Cerca con Google

Valentine, B.A., N.J. Winand, D. Pradhan, N.S. Moise, A. de Lahunta, J.N. Kornegay, and B.J. Cooper. 1992. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am J Med Genet. 42:352-356. Cerca con Google

van Deutekom, J.C., A.A. Janson, I.B. Ginjaar, W.S. Frankhuizen, A. Aartsma-Rus, M. Bremmer-Bout, J.T. den Dunnen, K. Koop, A.J. van der Kooi, N.M. Goemans, S.J. de Kimpe, P.F. Ekhart, E.H. Venneker, G.J. Platenburg, J.J. Verschuuren, and G.J. van Ommen. 2007. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med. 357:2677-2686. Cerca con Google

van Geel, M., M.C. Dickson, A.F. Beck, D.J. Bolland, R.R. Frants, S.M. van der Maarel, P.J. de Jong, and J.E. Hewitt. 2002. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics. 79:210-217. Cerca con Google

Vauchez, K., J.P. Marolleau, M. Schmid, P. Khattar, A. Chapel, C. Catelain, S. Lecourt, J. Larghero, M. Fiszman, and J.T. Vilquin. 2009. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther. 17:1948-1958. Cerca con Google

Villalta, S.A., H.X. Nguyen, B. Deng, T. Gotoh, and J.G. Tidball. 2009. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet. 18:482-496. Cerca con Google

Villalta, S.A., C. Rinaldi, B. Deng, G. Liu, B. Fedor, and J.G. Tidball. 2011. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet. Cerca con Google

Vilquin, J.T., B. Guerette, J. Puymirat, D. Yaffe, F.M. Tome, M. Fardeau, M. Fiszman, K. Schwartz, and J.P. Tremblay. 1999. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles. Gene Ther. 6:792-800. Cerca con Google

Vilquin, J.T., J.P. Marolleau, S. Sacconi, I. Garcin, M.N. Lacassagne, I. Robert, B. Ternaux, B. Bouazza, J. Larghero, and C. Desnuelle. 2005. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther. 12:1651-1662. Cerca con Google

Wang, B., J. Li, and X. Xiao. 2000. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci U S A. 97:13714-13719. Cerca con Google

Wang, Z., T. Zhu, C. Qiao, L. Zhou, B. Wang, J. Zhang, C. Chen, J. Li, and X. Xiao. 2005. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol. 23:321-328. Cerca con Google

Welch, E.M., E.R. Barton, J. Zhuo, Y. Tomizawa, W.J. Friesen, P. Trifillis, S. Paushkin, M. Patel, C.R. Trotta, S. Hwang, R.G. Wilde, G. Karp, J. Takasugi, G. Chen, S. Jones, H. Ren, Y.C. Moon, D. Corson, A.A. Turpoff, J.A. Campbell, M.M. Conn, A. Khan, N.G. Almstead, J. Hedrick, A. Mollin, N. Risher, M. Weetall, S. Yeh, A.A. Branstrom, J.M. Colacino, J. Babiak, W.D. Ju, S. Hirawat, V.J. Northcutt, L.L. Miller, P. Spatrick, F. He, M. Kawana, H. Feng, A. Jacobson, S.W. Peltz, and H.L. Sweeney. 2007. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 447:87-91. Cerca con Google

Wertz, K., and E.M. Fuchtbauer. 1998. Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene. Dev Dyn. 212:229-241. Cerca con Google

Whalen, R.G., J.B. Harris, G.S. Butler-Browne, and S. Sesodia. 1990. Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. Dev Biol. 141:24-40. Cerca con Google

Wijmenga, C., J.E. Hewitt, L.A. Sandkuijl, L.N. Clark, T.J. Wright, H.G. Dauwerse, A.M. Gruter, M.H. Hofker, P. Moerer, R. Williamson, and et al. 1992. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 2:26-30. Cerca con Google

Willmann, R., S. Possekel, J. Dubach-Powell, T. Meier, and M.A. Ruegg. 2009. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord. 19:241-249. Cerca con Google

Wilton, S.D., A.M. Fall, P.L. Harding, G. McClorey, C. Coleman, and S. Fletcher. 2007. Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. Mol Ther. 15:1288-1296. Cerca con Google

Winand, N.J., M. Edwards, D. Pradhan, C.A. Berian, and B.J. Cooper. 1994. Deletion of the dystrophin muscle promoter in feline muscular dystrophy. Neuromuscul Disord. 4:433-445. Cerca con Google

Wolff, J.A., R.W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P.L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science. 247:1465-1468. Cerca con Google

Wozniak, A.C., O. Pilipowicz, Z. Yablonka-Reuveni, S. Greenway, S. Craven, E. Scott, and J.E. Anderson. 2003. C-Met expression and mechanical activation of satellite cells on cultured muscle fibers. J Histochem Cytochem. 51:1437-1445. Cerca con Google

Wright, W.E., D.A. Sassoon, and V.K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 56:607-617. Cerca con Google

Wu, B., B. Xiao, C. Cloer, M. Shaban, A. Sali, P. Lu, J. Li, K. Nagaraju, X. Xiao, and Q.L. Lu. 2011. One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice. Mol Ther. 19:576-583. Cerca con Google

Yablonka-Reuveni, Z., and A.J. Rivera. 1994. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol. 164:588-603. Cerca con Google

Yamanaka, S. 2010. Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell. 7:1-2. Cerca con Google

Yamanaka, S., J. Li, G. Kania, S. Elliott, R.P. Wersto, J. Van Eyk, A.M. Wobus, and K.R. Boheler. 2008. Pluripotency of embryonic stem cells. Cell Tissue Res. 331:5-22. Cerca con Google

Yan, Z., S. Choi, X. Liu, M. Zhang, J.J. Schageman, S.Y. Lee, R. Hart, L. Lin, F.A. Thurmond, and R.S. Williams. 2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem. 278:8826-8836. Cerca con Google

Yang, S.Y., and G. Goldspink. 2002. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 522:156-160. Cerca con Google

Ye, L., S. Zhang, L. Greder, J. Dutton, S.A. Keirstead, M. Lepley, L. Zhang, D. Kaufman, and J. Zhang. 2013. Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF. PLoS One. 8:e53764. Cerca con Google

Yokota, T., Q.L. Lu, T. Partridge, M. Kobayashi, A. Nakamura, S. Takeda, and E. Hoffman. 2009. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol. 65:667-676. Cerca con Google

Yue, Y., M. Liu, and D. Duan. 2006. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice. Mol Ther. 14:79-87. Cerca con Google

Zammit, P.S., T.A. Partridge, and Z. Yablonka-Reuveni. 2006. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem. 54:1177-1191. Cerca con Google

Zheng, B., B. Cao, M. Crisan, B. Sun, G. Li, A. Logar, S. Yap, J.B. Pollett, L. Drowley, T. Cassino, B. Gharaibeh, B.M. Deasy, J. Huard, and B. Peault. 2007. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol. 25:1025-1034. Cerca con Google

Zhu, C.H., V. Mouly, R.N. Cooper, K. Mamchaoui, A. Bigot, J.W. Shay, J.P. Di Santo, G.S. Butler-Browne, and W.E. Wright. 2007. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell. 6:515-523. Cerca con Google

Zierath, J.R., and J.A. Hawley. 2004. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol. 2:e348. Cerca con Google

Zincarelli, C., S. Soltys, G. Rengo, and J.E. Rabinowitz. 2008. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 16:1073-1080. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record